Upgrade to SI Premium - Free Trial

Fortress Biotech (FBIO)

1.97 +0.03 (1.55%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

Form 8-K MUSTANG BIO, INC. For: Oct 13 October 15, 2026 4:06 PM - SEC Filing Form 8-K Fortress Biotech, Inc. For: Sep 30 October 1, 2026 4:31 PM - SEC Filing Form 4 Fortress Biotech, Inc. For: Oct 01 Filed by: Jin David October 1, 2026 4:31 PM - SEC Filing Journey Medical Corporation to Participate in September 2026 Investor Conferences September 8, 2026 4:05 PM - StreetInsider Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference September 8, 2026 8:00 AM - StreetInsider Form 10-Q Fortress Biotech, Inc. For: Jun 30 August 13, 2026 4:33 PM - SEC Filing Form 8-K Fortress Biotech, Inc. For: Aug 13 August 13, 2026 4:16 PM - SEC Filing Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights August 13, 2026 4:05 PM - StreetInsider Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights August 12, 2026 4:01 PM - StreetInsider Form 10-Q MUSTANG BIO, INC. For: Jun 30 August 5, 2026 4:02 PM - SEC Filing Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 August 5, 2026 8:30 AM - StreetInsider Crystalys Therapeutics closes $130M Series B to fund gout drug trials July 27, 2026 8:04 AM - StreetInsider Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing July 27, 2026 8:00 AM - StreetInsider Full Article List